Sign Up Today and Learn More About Nuvig Therapeutics Stock
Invest in or calculate the value of your shares in Nuvig Therapeutics or other pre-IPO companies through EquityZen's platform.
Nuvig Therapeutics Stock (NUTH)
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
About Nuvig Therapeutics Stock
Founded
2021
Headquarters
Redwood City, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Nuvig Therapeutics Press Mentions
Stay in the know about the latest news on Nuvig Therapeutics
Modified FC polypeptides with enhanced sialylation
patents • Apr 02, 2025
LOTTE Holdings’s Healthcare and Biopharmaceutical CVC Made Its First Investment in Nuvig Therapeutics
einpresswire • Dec 09, 2024
Nuvig: $161 Million (Series B) Raised To Develop Novel Immunomodulatory Therapeutics
pulse2 • Dec 09, 2024
Nuvig Therapeutics Raises $161M in Series B Funding
finsmes • Dec 07, 2024
The Week’s Biggest Funding Rounds: Tenstorrent And Nuvig Top List
news • Dec 06, 2024
Nuvig Therapeutics Management
Leadership team at Nuvig Therapeutics
Chief Scientific Officer and Co-founder
Pamela Conley
CEO
Julie Anne Smith
Join now and verify your accreditation status to gain access to:
- Nuvig Therapeutics Current Valuation
- Nuvig Therapeutics Stock Price
- Nuvig Therapeutics Management
- Available deals in Nuvig Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nuvig Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Nuvig Therapeutics Revenue and Financials
- Nuvig Therapeutics Highlights
- Nuvig Therapeutics Business Model
- Nuvig Therapeutics Risk Factors
- Nuvig Therapeutics Research Report from SACRA Research
Trading Nuvig Therapeutics Stock
How to invest in Nuvig Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Nuvig Therapeutics through EquityZen funds. These investments are made available by existing Nuvig Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nuvig Therapeutics stock?
Shareholders can sell their Nuvig Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
